NIMH to Fund Neurological Disorder-related Microdeletion Studies | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Mental Health will award around $3 million to fund as many as six projects that pursue research into a genetic microdeletion that has been associated with a range of neuropsychiatric disorders.

The new funding program seeks to support projects that will expand the research conducted by the International 22q11 Deletion Syndrome Research Consortium, a group of around 120 investigators spread across 20 countries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."